Bortezomib: Difference between revisions

Revision as of 16:38, 14 November 2022

Revision as of 16:34, 14 November 2022 (view source) Aidan (talk \| contribs) (Created page with "* Used for multiple myeloma and mantle cell lymphoma Category:Medications Category:Hematology Category:Oncology") Tag: Visual edit		Revision as of 16:38, 14 November 2022 (view source) Aidan (talk \| contribs) mNo edit summary Tag: Visual edit Newer edit →
Line 1:		Line 1:
			* [[Proteasome inhibitor]]
	* Used for [[multiple myeloma]] and [[mantle cell lymphoma]]		* Used for [[multiple myeloma]] and [[mantle cell lymphoma]]